In collaboration with the World Health Organization, the MPP held its third industry event to brief private sector partners on progress in medicine development and rollout on 27 March in Geneva. This year’s discussion, Forecasts vs. Reality: Are we on Course? focused on MPP-WHO developed joint forecasts for HIV medicines as well as hepatitis C treatment uptake. MPP’s Sandeep Juneja and Aastha Juneja and the WHO’s Daniel Low-Beer, Boniface Dongmo, Vincent Habiyambere and Marc Bulterys were among presenters. Shailesh Pedneker, Hetero; Helen McDowell, ViiV Healthcare; Prashant Sisodia, Mylan and Martin Auton from the Global Fund participated in the event as well.
Access the MPP-WHO forecast presentation: Forecasted demand for Current and New ARV medicines in low- and middle-income countries, 2016-2026